Xlife Sciences with pleasing progress in the first half of 2022

Xlife Sciences AG / Key word(s): Half Year Results28-Sep-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Xlife Sciences (SIX: XLS) today published its results for the first half of 2022 ending 30 June 2022. Oliver R. B...

Related Keywords

Germany ,Zurich ,Züsz ,Switzerland ,United States ,Munich ,Bayern ,Talacker ,Baden Wüberg ,Ukraine ,German ,Swiss ,Oliverr Baumann ,Dennis Lennartz ,Thoraxklinik Heidelberg Gmb ,Roche Pharma ,Valentin Handschin ,Munich Stock Exchange ,Technology Association ,Thuringia Ministry Of Economics ,Stock Exchange ,Swiss Exchange ,Device Single Audit Program ,Xlife Sciences Ag Key ,Evonik Industries ,Xlife Sciences ,Thuringia Research ,Half Year ,Xlife Science ,Munich Stock ,Evonik Venture Capital ,Venture Capital ,University Medicine ,Johannes Gutenberg University Mainz ,Thoraxklinik Heidelberg ,Thuringia Ministry ,Prostate Carcinoma ,Medical Device Single Audit Program ,Year Report ,